glp-1 and cancer risk Glucagon-like peptide 1 receptor agonists risk: the good, the bad and the unknown VisualAbstract: Glucagon-like peptide 1 receptor

Sub nanotechnology allows glutathione to effortlessly absorb into skin, the company says

Majzoub AM, Nayfeh T, Barnard A, Munaganuru N, Dave S, Singh S, et al

This CS could be a way to overcome the poor prognosis for patients suffering from a chemoresistant cancer

Rebuilding muscle becomes more challenging, which is why the British Menopause Society emphasises the non-negotiable importance of strength-building exercises for women in perimenopause and menopause

Retatrutide Regulatory Status As of June 2026, retatrutide is not approved by the FDA, the EMA, or any other regulatory agency

If you're not satisfied with your order and wish to return one or more items, please contact our Customer Care Team at [email protected] within 14 days of delivery